Effect of Rimonabant, a Cannabinoid-1 Receptor Blocker, on Weight and Cardiometabolic Risk Factors in Overweight or Obese PatientsF. Xavier Pi-Sunyer,Louis J. Aronne,Hassan M. Heshmati, Jeanne Devin,Julio Rosenstock, for the RIO-North America Study GroupJAMA（2006）引用 1190|浏览0暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
